Anti-inflammatory activity of patchouli alcohol in RAW264.7 and HT-29 cells

Food and Chemical Toxicology

Volumn 55, Issue , 2013, Pages 229-233

  Jeong, Jin Boo ^a   Shin, Yong Kyu ^a   Lee, Seong Ho ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

Anti inflammation; ERK; NF B; Patchouli alcohol

Indexed keywords

ANTIINFLAMMATORY AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PATCHOULI ALCOHOL; SESQUITERPENE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CANCER CELL CULTURE; COLORECTAL CANCER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG MECHANISM; ENZYMATIC DEGRADATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; MOUSE; NONHUMAN; POGOSTEMON CABLIN;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BASE SEQUENCE; CELL LINE; DNA PRIMERS; HT29 CELLS; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SESQUITERPENES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84873557169     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.12.062     Document Type: Article

References (24)

1. Andreakos E., Foxwell B., Feldmann M. Is targeting toll-like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine-driven inflammation?. Immunol. Rev. 2004, 202:250-265.
2. Bhatia S.P., Letizia C.S., Api A.M. Fragrance material review on patchouli alcohol. Food Chem. Toxicol. 2008, 46:255-256.
3. Bjarnason I., Hayllar J., MacPherson A.J., Russell A.S. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 1993, 104:1832-1847.
4. Bogdan C. Nitric oxide and the immune response. Nat. Immunol. 2001, 10:907-916.
5. Dinarello C.A. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest 1997, 112:321-329.
6. Gilmore T.M. Introduction to NF-kappa B: plays, pathways, perspectives. Oncogene 2006, 25:6680-6684.
7. Hobbs A.J., Higgs A., Moncada S. Inhibition of nitric oxide synthase as a potential therapeutic target. Annu. Rev. Pharmacol. Toxicol. 1999, 39:191-220.
8. Huang X.W., Bai L., Xu F.H., Wu Y.J. Inhibitory activities of patchouli alcohol on neurotoxicity of β-amyloid peptide. Med. J. Chin. People Liberation Army 2008, 24:338-340.
9. Huang X.W., Liu R.T., Lü Q.J. Patchouli alcohol on memory impairment induced by scopolamine learning and memory function in mice. Chin. Herb Drug 2009, 40:1431-1433.
10. Jenkins D.C., Charles I.G., Baylis S.A., Lelchuk R., Radomski M.W., Moncada S. Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation. Br. J. Cancer 1994, 70:847-849.
11. Kiyohara H., Ichino C., Kawamura Y., Nagai T., Sato N., Yamada H. Patchouli alcohol: in vitro direct anti-influenza virus sesquiterpene in Pogostemon cablin Benth. J. Nat. Med. 2012, 66:55-61.
12. Lee, G.R., Shin, M.K., Yoon, D.J., Kim, A.R., Park, N.W., Yu, R., Han, I.S., 2012. Topical application of capsaicin reduces visceral adipose fat by affecting adipokine levels in high-fat diet (HFD)-induced obese mice. Obesity (Silver Spring), June 18. doi: doi:10.1038/oby.2012.166.
13. Li Y.C., Xian Y.F., Ip S.P., Su Z.R., Su J.Y., He J.J., Xie Q.F., Lai X.P., Lin Z.X. Anti-inflammatory activity of patchouli alcohol isolated from Pogostemonis Herba in animal models. Fitoterapia 2011, 82:1295-1301.
14. MacMicking J.X., Xie Q.W., Nathan C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 1997, 15:323-350.
15. Mankan A.K., Lawless M.W., Gray S.G., Kelleher D., McManus R. NF-kappaB regulation: the nuclear response. J. Cell Mol. Med. 2009, 13:631-643.
16. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 1992, 6:3051-3064.
17. Palladino M.A., Bahjat F.R., Theodorakis E.A., Moldawe L.L. Anti-TNF-alpha therapies: the next generation. Natl. Rev. Drug Discov. 2003, 2:736-746.
18. Sarkar F.H., Li Y., Wang Z., Kong D. NF-kappaB signaling pathway and its therapeutic implications in human diseases. Int. Rev. Immunol. 2008, 27:293-319.
19. Schmidt H.H., Walter U. NO at work. Cell 1994, 78:919-925.
20. Singer I.I., Kawka D.W., Scott S., Weidner J.R., Mumford R.A., Riehl T.E., Stenson W.F. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 1996, 111:871-885.
21. Surh Y.J., Chun K.S., Cha H.H., Han S.S., Keum Y.S., Park K.K., Lee S.S. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation COX-2 and iNOS through suppression of NF-κB activation. Mutat. Res. 2001, 480-481:243-268.
22. Vanden Berghe W., Plaisance S., Boone E., De Bosscher K., Schmitz M.L., Fiers W., Haegeman G. P38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor. J. Biol. Chem. 1998, 273:3285-3290.
23. Walsh N.C., Crotti T.N., Goldring S.R., Gravallese E.M. Rheumatic diseases: the effects of inflammation on bone. Immunol. Rev. 2005, 208:228-251.
24. Xian Y.F., Li Y.C., Ip S.P., Lin Z.X., Lai X.P., Su Z.R. Anti-inflmmatory effect of patchouli alcohol isolated from Pogostemonis Herba in LPS-stimulated RAW264.7 macrophages. Exp. Ther. Med. 2011, 2:545-550.